Scope of the
Report
The report entitled “US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021)”, provides analysis of the US DESS market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value (TAM), by volume and by utilization. The report also provides the analysis of the US sinus surgery market, including analysis of FESS market and BSD market.
The report entitled “US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021)”, provides analysis of the US DESS market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value (TAM), by volume and by utilization. The report also provides the analysis of the US sinus surgery market, including analysis of FESS market and BSD market.
Get More Information of US Drug Eluting Sinus
Stent (DESS) Market Report @ http://www.orbisresearch.com/reports/index/us-drug-eluting-sinus-stent-dess-market-size-trends-and-forecasts-2016-2021 .
Furthermore, the
report also assesses the key opportunities in the market and outlines the
factors that are and will be driving the growth of the industry. Growth of the
overall US DESS market has also been forecasted for the years 2016-2021, taking
into consideration the growth pattern of sinus surgery market, the growth
drivers and the current and future trends.
Intersect is the only
company manufacturing drug eluting sinus stents, but the competitive landscape
of the market includes other indirect competitors, such as Medtronic, Entellus
Medical and Acclarent (J&J), whose company profiling has been done in the
report. In this segment of the report, business overview, financial overview
and business strategies of the companies are provided.
Purchase a copy of US Drug Eluting Sinus Stent
(DESS) Market visit @ http://www.orbisresearch.com/contact/purchase/185412 . For more information contact sales@orbisresearch.com .
Company Coverage
Intersect ENT
Medtronic (Xomed)
Entellus Medical
Acclarent (J&J)
Intersect ENT
Medtronic (Xomed)
Entellus Medical
Acclarent (J&J)
Executive Summary
Sinuses are the hollow cavities located in the bones of the face and around the nose. There are four sinus cavities: frontal, maxillary, ethmoid, and sphenoid, each with different features. Under normal conditions, the secretion (mucous) flow through the nasal passages, but with the onset of sinusitis, the secretion gets blocked in the sinuses due to inflammation. Sinusitis disturbs the normal lifestyle of a person and sometimes become frustrating, as it affects the person’s breathing, sleeping and eating.
Sinuses are the hollow cavities located in the bones of the face and around the nose. There are four sinus cavities: frontal, maxillary, ethmoid, and sphenoid, each with different features. Under normal conditions, the secretion (mucous) flow through the nasal passages, but with the onset of sinusitis, the secretion gets blocked in the sinuses due to inflammation. Sinusitis disturbs the normal lifestyle of a person and sometimes become frustrating, as it affects the person’s breathing, sleeping and eating.
Sinusitis can be
divided into Acute Sinusitis, Recurrent Acute Rhinosinusitis (RARS) and chronic
Rhinosinusitis (CRS), on the basis of the duration of the episode of sinusitis
and its severity. The treatment options for the sinusitis can be
over-the-counter treatment, medical management and surgery. The OTC treatment
includes decongestants, antihistamines, pain relievers and nasal irrigation.
Medical management includes antibiotics and oral and nasal steroids. The sinus
surgeries are mainly of two types: Functional Endoscopic Sinus Surgery (FESS)
and Balloon Sinus Dilation (BSD).
Intersect, is the
only company that has developed drug releasing bio-absorbable implants (drug
eluting sinus stents- DESS) that enable targeted and sustained release of
therapeutic agents, increasing the effectiveness of the sinus surgery.
The US DESS market is
expected to increase at a significant growth rate during the forecasted period (2016-2021).
The US DESS market is supported by various growth drivers, such as limitations
of FESS treatment, benefits of DESS, increasing per capita healthcare
expenditure, cost effectiveness of DESS, etc. Yet, the market faces certain
challenges, such as, reimbursement issues, dependability on individual
physician’s experience, limited trials after BSD, etc.
Request a sample of US Drug Eluting Sinus Stent
(DESS) market @ http://www.orbisresearch.com/contacts/request-sample/185412
.
Some points from TOC:
1. Executive Summary
2. Introduction
2.1 Sinus Overview
2.1.1 Types of Sinus
2.2 Sinusitis Overview
2.2.1 Types of Sinusitis
2.2.2 Treatment Options
2.3 Drug Eluting Sinus Stents (DESS) Overview
2.1 Sinus Overview
2.1.1 Types of Sinus
2.2 Sinusitis Overview
2.2.1 Types of Sinusitis
2.2.2 Treatment Options
2.3 Drug Eluting Sinus Stents (DESS) Overview
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact
Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1
(214) 884-6817; +9164101019
No comments:
Post a Comment